Showing results (211-220 of 343) with videos related to
Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish studyAndrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.Haematologica|April 26, 2014
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapyMaría-Victoria Mateos, Sara Bringhen, Paul G Richardson, et al.Haematologica|February 9, 2019
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studiesSara Bringhen, Roberto Mina, Maria Teresa Petrucci, et al.Current Oncology (Toronto, Ont.)|November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real LifeManlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.American Journal of Hematology|July 29, 2016
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patientsStefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.British Journal of Haematology|February 13, 2003
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical featuresRobin Foa, Antonella Vitale, Marco Mancini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myelomaMichele Cavo, Francesco Di Raimondo, Elena Zamagni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor projectMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid LeukemiaMariarita Spampinato, Tatiana Zuppelli, Ilaria Dulcamare, et al.British Journal of Haematology|December 21, 2010
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD coursesAndrea Gallamini, Caterina Patti, Simonetta Viviani, et al.Pageof 35